XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Net Income (Loss) Per Share | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
Net Income (Loss) Per Share | 3. Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing the net income (loss) by the weighted-average number of shares of common stock outstanding for the period. Diluted net income (loss) per share is calculated using the weighted-average number of common shares outstanding, plus potential dilutive common stock during the period. Diluted net loss per share is the same as basic net loss per share in the period when the effect of the potentially dilutive securities is anti-dilutive. The pre-funded warrants are included in both the basic and diluted EPS calculation. The following table presents the calculation of basic and diluted net income (loss) per share:
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |
Net income (loss) |  | $ | 31,869 |  |  | $ | (569 | )
Denominator: |  |  |  |  |  |
Basic |  |  |  |  |  |
Weighted-average common shares outstanding |  |  | 77,516,177 |  |  |  | 66,655,971 |
Weighted-average pre-funded warrants |  |  | 6,923,126 |  |  |  | 7,152,266 |
Weighted-average common shares outstanding used to calculate basic net income (loss) per share |  |  | 84,439,303 |  |  |  | 73,808,237 |
Diluted |  |  |  |  |  |
Weighted-average common shares outstanding used to calculate basic net income (loss) per share |  |  | 84,439,303 |  |  |  | 73,808,237 |
Effect of potentially dilutive securities: |  |  |  |  |  |
Stock options, ESPP & RSUs |  |  | 305,813 |  |  |  | — |
Weighted-average common shares outstanding used to calculate diluted net income (loss) per share |  |  | 84,745,116 |  |  |  | 73,808,237 |
Net income (loss) per share, basic and diluted |  |  |  |  |  |
Basic |  | $ | 0.38 |  |  | $ | (0.01 | )
Diluted |  | $ | 0.38 |  |  | $ | (0.01 | )
The following weighted-average outstanding shares of potentially dilutive securities are excluded from the computation of diluted net loss per share for the periods presented, because including them would have been anti-dilutive:
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Options and ESPP to purchase common stock |  |  | 14,452,982 |  |  |  | 13,805,472 |
Common stock warrants |  |  | 11,538,462 |  |  |  | 5,675,167 |
RSUs |  |  | 227,925 |  |  |  | 1,820,589 |
Total |  |  | 26,219,369 |  |  |  | 21,301,228 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration